Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Lang

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Clinical Genitourinary Cancer|July 10, 2013
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapyJoshua M Lang, Marianne Wallace, Jordan T Becker, et al.
Urology|September 27, 2016
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric AnalysisMichael L Blute, Timothy J Ziemlewicz, Joshua M Lang, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
Molecular Oncology|April 8, 2020
Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancerAshok Singh, Ryan A Denu, Serena K Wolfe, et al.
Methods (San Diego, Calif.)|June 29, 2013
A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cellsBenjamin P Casavant, Rachel Mosher, Jay W Warrick, et al.
International Journal of Molecular Sciences|February 13, 2026
Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a ChipNikolett Lupsa, Erika Heninger, Adeline B Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003Arkadiusz Z Dudek, Li C Liu, Shilpa Gupta, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
Oncotarget|October 22, 2016
Inducible expression of cancer-testis antigens in human prostate cancerErika Heninger, Timothy E G Krueger, Stephanie M Thiede, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Clinical Genitourinary Cancer|July 10, 2013
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapyJoshua M Lang, Marianne Wallace, Jordan T Becker, et al.
Urology|September 27, 2016
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric AnalysisMichael L Blute, Timothy J Ziemlewicz, Joshua M Lang, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
Molecular Oncology|April 8, 2020
Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancerAshok Singh, Ryan A Denu, Serena K Wolfe, et al.
Methods (San Diego, Calif.)|June 29, 2013
A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cellsBenjamin P Casavant, Rachel Mosher, Jay W Warrick, et al.
International Journal of Molecular Sciences|February 13, 2026
Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a ChipNikolett Lupsa, Erika Heninger, Adeline B Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003Arkadiusz Z Dudek, Li C Liu, Shilpa Gupta, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
Oncotarget|October 22, 2016
Inducible expression of cancer-testis antigens in human prostate cancerErika Heninger, Timothy E G Krueger, Stephanie M Thiede, et al.
Pageof 11